顶部logo
顶部logo
more_1

home

ホーム > レポート一覧 > グローバル婦人科用薬市場規模、主要企業シェア、ランキング分析レポート【2026年版】

グローバル婦人科用薬市場規模、主要企業シェア、ランキング分析レポート【2026年版】

Gynecological Conditions Medications - Global Top Players Market Share and Ranking 2026
  • レポートID：
    223590
  • 発表時期：
    2026-03-03
  • レポート形式：
    PDF
  • 産業カテゴリー：
    薬品及びサプリメント
  • レポート言語：
    英語、日本語
  • ページ数：
    115
  • 発行会社（調査会社）：
    YHResearch
title

言語とエディションの価格

  • 英語版
  • 日本語版
  • 英語と日本語版

個人版詳細

マルチユーザー版詳細

企業版詳細

  • 英語版
  • 日本語版
  • 英語と日本語版

価格表記: USDを日本円(税抜)に換算，本日の銀行送金レート: 1USD=162.40円。

※米ドル表示価格+10％消費税。

※ご注文方法：お問い合わせフォームまたはメールにてご連絡ください。
支払方法：「銀行振込」の場合， 注文の確認後、ご指定のメールアドレスに電子版の請求書をお送りいたしますので、電子版の請求書の記載事項に従って送金操作を行ってください。
※納期：原則として、受注後2～4営業日以内に発送いたします。 但し、日本語版が必要な場合は、受注後8～10営業日となります。 お客様のニーズに合わせて、事前にご注文のスケジュールをお立てください。

title

レポートの概要

本報告書は、世界の婦人科用薬市場について包括的な分析を行い、市場全体の動向を明らかにすることを目的としています。総販売数量、売上高、価格動向に加え、主要企業の市場シェアおよび順位を整理し、市場構造を多角的に把握します。さらに、地域・国別、製品タイプ別、用途分野別などの観点から婦人科用薬市場を分析し、需要構造と成長特性を明確化します。
婦人科用薬市場の規模、推定値および予測は、2025年を基準年とし、2021年から2032年までの期間における販売数量および売上高に基づいて提示しています。定量分析と定性分析を組み合わせることで、ビジネスおよび成長戦略を検討し、市場競争環境を評価し、企業の市場ポジションを把握した上で、婦人科用薬に関する的確な意思決定を行うための実践的なインサイトを提供します。
 主要婦人科用薬市場の統計
2025年世界市場規模：21600百万米ドル
2026年世界市場規模：22400百万米ドル
2032年予測市場規模：28090百万米ドル
2026–2032年予測期間CAGR：3.8%
本レポートは婦人科用薬市場の中長期的な成長動向を定量分析および定性分析の両面から体系的に整理しています。 
【市場セグメンテーション】
主要企業・競争環境
婦人科用薬市場の主要企業には以下が含まれます：
Bayer
Pfizer
Sanofi
Fuji Pharma
Edenbridge Pharmaceuticals
Lupin
Adorshea Bioceutics
Duchesnay
Perrigo
Prestige Consumer Healthcare
Combe Incorporated
Femcorp
Beijing Tongrentang
Qianjin Pharmaceutical
Enwei Pharmaceutical
Yunnan Baiyao 

製品別
Chinese Patent Medicine
Chemical Synthesis Medicine 

アプリケーション別
Hospital
Pharmacy
Online 

レポート対象地域
北米：アメリカ、カナダ、その他
アジア太平洋：中国、日本、韓国、東南アジア、インド、オーストラリア、その他
ヨーロッパ：ドイツ、フランス、イギリス、イタリア、オランダ、北欧諸国、その他
ラテンアメリカ：メキシコ、ブラジル、その他
中東・アフリカ：トルコ、サウジアラビア、UAE、その他

レポート構成（章別概要）
第1章｜市場概要と成長展望
婦人科用薬市場の全体像を整理し、市場規模、売上予測、価格推移を体系的に解説します。同時に成長要因、市場機会、業界課題、リスク要因を分析し、中長期的な市場展望を提示します
第2章｜主要企業の競争分析
婦人科用薬市場における主要プレイヤー（トップ5社・トップ10社）を対象に、売上高、製造拠点、製品構成、価格戦略、販売量、市場シェアを多面的に分析し、競争構造を明確化します
第3章｜製品カテゴリ別市場動向
製品タイプ別に婦人科用薬市場を分類し、売上高、市場シェア、販売量、価格動向を分析します。成長性の高い製品分野と市場構造の変化を明らかにします
第4章｜用途別市場動向
用途別に婦人科用薬市場規模、売上高、市場シェア、販売量、価格推移を整理し、業界別の需要動向と成長ポテンシャルを分析します
第5章｜地域別市場分析
地域別の市場成長率、販売量、売上高を詳細に分析し、婦人科用薬市場の地理的需要構造を可視化します。各地域の市場規模推移と将来の成長余地を評価します
第6章｜国別市場動向
主要国・地域ごとに、婦人科用薬市場の販売量、売上高、成長要因、政策・規制環境、競争特性を整理し、国別市場の特徴を明確にします
第7章｜主要企業プロファイル
婦人科用薬市場を牽引する主要企業について、売上高、販売量、価格動向、粗利益率、製品ポートフォリオ、最新の戦略動向を詳細に解説します
第8章｜バリューチェーンと市場構造分析
業界全体のサプライチェーンを上流から下流まで整理し、コスト構造や流通モデルの動向を分析します
第9章｜調査結果
調査結果を総括し、市場全体のトレンド、今後の成長機会、潜在的リスク、戦略的な洞察を提示します
第10章｜付録（調査手法・データソース）
調査設計、分析手法、使用データソースの詳細を明示し、レポートの信頼性と透明性を担保します

本レポートの要点と洞察
 婦人科用薬市場の全体像と成長見通し
婦人科用薬市場の規模変化の傾向、成長予測及び需要動向を体系的に整理いたします。2021年から2025年までの実績データに基づき、2032年までの中長期予測を提示し、市場の拡大速度と成長潜在力を明らかにします。同時に、最近の関税調整措置など各国の政策動向を踏まえ、多角的にグローバル経済環境が婦人科用薬市場に与える影響を分析いたします
 市場環境の構成要素とマクロトレンド
婦人科用薬産業を取り巻く市場環境について、需要構造の変化、政策対応、技術革新の進展といった主要要因を整理します。特に、国際貿易政策や関税政策の変化が企業戦略や価格形成に及ぼす影響、サプライチェーン再編の動きと事業運営への波及効果を明確化し、市場環境の全体像を包括的に提示します
 競争構造と主要企業の動向分析
婦人科用薬市場における主要企業の売上規模、市場シェア、競争ポジションを整理し、競争構造の特徴を分析します。各社の競争戦略、事業拡大の方向性、新製品・新技術の投入動向を通じて、技術革新が市場競争に与える影響と競争環境の変化を解読します
 競争環境と事業動向の把握
製品タイプ別、用途別、地域・国別の観点から婦人科用薬市場のセグメント構造を整理します。各地域の需要構成と成長特性を比較分析し、各細分領域が市場全体の成長に与える貢献度と相互関連性を明確にします
 成長要因・課題・リスクの分析
婦人科用薬市場の成長を支える主要ドライバーを整理するとともに、業界特有の課題や潜在的リスクを分析します。原材料調達、供給システム、事業運営における不確実性を踏まえ、サプライチェーン及び事業レジリエンス強化の方向性についても考察します
 将来トレンドと市場展望
婦人科用薬市場の中長期的な成長トレンドと将来の発展シナリオを提示します。持続的成長を実現するための重要な成功要因を整理し、今後の市場参入企業や既存プレイヤーの戦略的意思決定に参考となる視点を提供いたします
title

Description

According to YH Research, the global market for Gynecological Conditions Medications should grow from US$ 21600 million in 2025 to US$ 28090 million by 2032, with a CAGR of 3.8% for the period of 2026-2032.

Increasing population of female population and increasing competitive pressure on female have driven the growth of the market.
This report studies and analyses global Gynecological Conditions Medications status and future trends, to help determine the Gynecological Conditions Medications market size of the total market opportunity by Type, by Application, by company, and by region & country. This report is a detailed and comprehensive analysis of the world market for Gynecological Conditions Medications, and provides market size (US$ million) and Year-over-Year growth, considering 2025 as the base year.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

To assess the competitive environment within the market including supplier revenue, market share, and company profiles.

Highlights
(1) Global Gynecological Conditions Medications market size, history data 2021-2025, and forecast data 2026 -2032, (US$ million)
(2) Global Gynecological Conditions Medications by company, revenue, market share and industry ranking 2021-2026, (US$ million)
(3) Japan Gynecological Conditions Medications by company, revenue, market share and industry ranking 2021-2026, (US$ million)
(4) Global Gynecological Conditions Medications key consuming regions, consumption value and demand structure
(5) Gynecological Conditions Medications industry chains, upstream, midstream and downstream
Market segment by players, this report covers
    Bayer
    Pfizer
    Sanofi
    Fuji Pharma
    Edenbridge Pharmaceuticals
    Lupin
    Adorshea Bioceutics
    Duchesnay
    Perrigo
    Prestige Consumer Healthcare
    Combe Incorporated
    Femcorp
    Beijing Tongrentang
    Qianjin Pharmaceutical
    Enwei Pharmaceutical
    Yunnan Baiyao

Market segment by Type, covers
    Chinese Patent Medicine
    Chemical Synthesis Medicine

Market segment by Application, can be divided into
    Hospital
    Pharmacy
    Online

Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa
Report Includes:
Chapter 1: to describe Gynecological Conditions Medications product scope, global consumption value, Japan consumption value, development opportunities, challenges, trends, and policies
Chapter 2: Global Gynecological Conditions Medications market share and ranking of major manufacturers, revenue, 2021-2026
Chapter 3: Japan Gynecological Conditions Medications market share and ranking of major manufacturers, revenue, 2021-2026
Chapter 4: Gynecological Conditions Medications industry chain, upstream, medium-stream, and downstream
Chapter 5: Segment by Type, consumption value, percent & CAGR, 2021-2032
Chapter 6: Segment by Application, consumption value, percent & CAGR, 2021-2032
Chapter 7: Segment in regional level, consumption value, percent & CAGR, 2021-2032
Chapter 8: Segment in country level, consumption value, percent & CAGR, 2021-2032
Chapter 9: Company profile, introducing the basic situation of the main companies in the market in detail, including product specifications, application, recent development, revenue, gross margin
Chapter 10: Conclusions
title

Table of Contents

1 Market Overview
    1.1 Gynecological Conditions Medications Definition
    1.2 Global Gynecological Conditions Medications Market Size and Forecast
    1.3 Japan Gynecological Conditions Medications Market Size and Forecast
    1.4 Share of Japan Gynecological Conditions Medications Market with Respect to the Global Market
    1.5 Gynecological Conditions Medications Market Size: Japan VS Global Growth Rate, 2021-2032
    1.6 Gynecological Conditions Medications Market Dynamics
        1.6.1 Gynecological Conditions Medications Market Drivers
        1.6.2 Gynecological Conditions Medications Market Restraints
        1.6.3 Gynecological Conditions Medications Industry Trends
        1.6.4 Gynecological Conditions Medications Industry Policy
2 Global Leading Players and Market Share
    2.1 By Revenue of Gynecological Conditions Medications, Global Market Share by Company, 2021-2026
    2.2 Global Gynecological Conditions Medications Participants, Market Position (Tier 1, Tier 2, and Tier 3)
    2.3 Global Gynecological Conditions Medications Concentration Ratio
    2.4 Global Gynecological Conditions Medications Mergers & Acquisitions, Expansion Plans
    2.5 Global Gynecological Conditions Medications Major Companies Product Type
    2.6 Head Office and Area Served of Key Players
3 Japan Leading Players, Market Share and Ranking
    3.1 By Revenue of Gynecological Conditions Medications, Japan Market Share by Company, 2021-2026
    3.2 Japan Gynecological Conditions Medications Gynecological Conditions Medications Participants, Market Position (Tier 1, Tier 2, and Tier 3)
4 Industry Chain Analysis
    4.1 Gynecological Conditions Medications Industry Chain
    4.2 Gynecological Conditions Medications Upstream Analysis
        4.2.1 Gynecological Conditions Medications Core Raw Materials
        4.2.2 Main Manufacturers of Gynecological Conditions Medications Core Raw Materials
    4.3 Midstream Analysis
    4.4 Downstream Analysis
    4.5 Gynecological Conditions Medications Production Mode
    4.6 Gynecological Conditions Medications Procurement Model
    4.7 Gynecological Conditions Medications Industry Sales Model and Sales Channels
        4.7.1 Gynecological Conditions Medications Sales Model
        4.7.2 Gynecological Conditions Medications Typical Distributors
5 Sights by Type
    5.1 Gynecological Conditions Medications Classification by Type
        5.1.1 Chinese Patent Medicine
        5.1.2 Chemical Synthesis Medicine
    5.2 by Type, Global Gynecological Conditions Medications Consumption Value & CAGR, 2021 VS 2025 VS 2032
    5.3 by Type, Global Gynecological Conditions Medications Consumption Value, 2021-2032
6 Sights by Application
    6.1 Gynecological Conditions Medications Segment by Application
        6.1.1 Hospital
        6.1.2 Pharmacy
        6.1.3 Online
    6.2 by Application, Global Gynecological Conditions Medications Consumption Value & CAGR, 2021 VS 2025 VS 2032
    6.3 by Application, Global Gynecological Conditions Medications Consumption Value, 2021-2032
7 Sales Sights by Region
    7.1 By Region, Global Gynecological Conditions Medications Consumption Value, 2021 VS 2025 VS 2032
    7.2 By Region, Global Gynecological Conditions Medications Consumption Value, 2021-2032
    7.3 North America
        7.3.1 North America Gynecological Conditions Medications Market Size & Forecasts, 2021-2032
        7.3.2 By Country, North America Gynecological Conditions Medications Market Size Market Share
    7.4 Europe
        7.4.1 Europe Gynecological Conditions Medications Market Size & Forecasts, 2021-2032
        7.4.2 By Country, Europe Gynecological Conditions Medications Market Size Market Share
    7.5 Asia Pacific
        7.5.1 Asia Pacific Gynecological Conditions Medications Market Size & Forecasts, 2021-2032
        7.5.2 By Country/Region, Asia Pacific Gynecological Conditions Medications Market Size Market Share
    7.6 South America
        7.6.1 South AmericaGynecological Conditions Medications Market Size & Forecasts, 2021-2032
        7.6.2 By Country, South America Gynecological Conditions Medications Market Size Market Share
    7.7 Middle East & Africa
8 Sales Sights by Country Level
    8.1 By Country, Global Gynecological Conditions Medications Market Size & CAGR, 2021 VS 2025 VS 2032
    8.2 By Country, Global Gynecological Conditions Medications Consumption Value, 2021-2032
    8.3 United States
        8.3.1 United States Gynecological Conditions Medications Market Size, 2021-2032
        8.3.2 by Type, United States Gynecological Conditions Medications Consumption Value Market Share, 2025 VS 2032
        8.3.3 by Application, United States Gynecological Conditions Medications Consumption Value Market Share, 2025 VS 2032
    8.4 Europe
        8.4.1 Europe Gynecological Conditions Medications Market Size, 2021-2032
        8.4.2 by Type, Europe Gynecological Conditions Medications Consumption Value Market Share, 2025 VS 2032
        8.4.3 by Application, Europe Gynecological Conditions Medications Consumption Value Market Share, 2025 VS 2032
    8.5 China
        8.5.1 China Gynecological Conditions Medications Market Size, 2021-2032
        8.5.2 by Type, China Gynecological Conditions Medications Consumption Value Market Share, 2025 VS 2032
        8.5.3 by Application, China Gynecological Conditions Medications Consumption Value Market Share, 2025 VS 2032
    8.6 Japan
        8.6.1 Japan Gynecological Conditions Medications Market Size, 2021-2032
        8.6.2 by Type, Japan Gynecological Conditions Medications Consumption Value Market Share, 2025 VS 2032
        8.6.3 by Application, Japan Gynecological Conditions Medications Consumption Value Market Share, 2025 VS 2032
    8.7 South Korea
        8.7.1 South Korea Gynecological Conditions Medications Market Size, 2021-2032
        8.7.2 by Type, South Korea Gynecological Conditions Medications Consumption Value Market Share, 2025 VS 2032
        8.7.3 by Application, South Korea Gynecological Conditions Medications Consumption Value Market Share, 2025 VS 2032
    8.8 Southeast Asia
        8.8.1 Southeast Asia Gynecological Conditions Medications Market Size, 2021-2032
        8.8.2 by Type, Southeast Asia Gynecological Conditions Medications Consumption Value Market Share, 2025 VS 2032
        8.8.3 by Application, Southeast Asia Gynecological Conditions Medications Consumption Value Market Share, 2025 VS 2032
    8.9 India
        8.9.1 India Gynecological Conditions Medications Market Size, 2021-2032
        8.9.2 by Type, India Gynecological Conditions Medications Consumption Value Market Share, 2025 VS 2032
        8.9.3 by Application, India Gynecological Conditions Medications Consumption Value Market Share, 2025 VS 2032
    8.10 Middle East & Africa
        8.10.1 Middle East & Africa Gynecological Conditions Medications Market Size, 2021-2032
        8.10.2 by Type, Middle East & Africa Gynecological Conditions Medications Consumption Value Market Share, 2025 VS 2032
        8.10.3 by Application, Middle East & Africa Gynecological Conditions Medications Consumption Value Market Share, 2025 VS 2032
9 Company Profile
    9.1 Bayer
        9.1.1 Bayer Company Information, Head Office, Market Area, and Industry Position
        9.1.2 Bayer Company Profile and Main Business
        9.1.3 Bayer Gynecological Conditions Medications Models, Specifications, and Application
        9.1.4 Bayer Gynecological Conditions Medications Revenue and Gross Margin, 2021-2026
        9.1.5 Bayer Recent Developments
    9.2 Pfizer
        9.2.1 Pfizer Company Information, Head Office, Market Area, and Industry Position
        9.2.2 Pfizer Company Profile and Main Business
        9.2.3 Pfizer Gynecological Conditions Medications Models, Specifications, and Application
        9.2.4 Pfizer Gynecological Conditions Medications Revenue and Gross Margin, 2021-2026
        9.2.5 Pfizer Recent Developments
    9.3 Sanofi
        9.3.1 Sanofi Company Information, Head Office, Market Area, and Industry Position
        9.3.2 Sanofi Company Profile and Main Business
        9.3.3 Sanofi Gynecological Conditions Medications Models, Specifications, and Application
        9.3.4 Sanofi Gynecological Conditions Medications Revenue and Gross Margin, 2021-2026
        9.3.5 Sanofi Recent Developments
    9.4 Fuji Pharma
        9.4.1 Fuji Pharma Company Information, Head Office, Market Area, and Industry Position
        9.4.2 Fuji Pharma Company Profile and Main Business
        9.4.3 Fuji Pharma Gynecological Conditions Medications Models, Specifications, and Application
        9.4.4 Fuji Pharma Gynecological Conditions Medications Revenue and Gross Margin, 2021-2026
        9.4.5 Fuji Pharma Recent Developments
    9.5 Edenbridge Pharmaceuticals
        9.5.1 Edenbridge Pharmaceuticals Company Information, Head Office, Market Area, and Industry Position
        9.5.2 Edenbridge Pharmaceuticals Company Profile and Main Business
        9.5.3 Edenbridge Pharmaceuticals Gynecological Conditions Medications Models, Specifications, and Application
        9.5.4 Edenbridge Pharmaceuticals Gynecological Conditions Medications Revenue and Gross Margin, 2021-2026
        9.5.5 Edenbridge Pharmaceuticals Recent Developments
    9.6 Lupin
        9.6.1 Lupin Company Information, Head Office, Market Area, and Industry Position
        9.6.2 Lupin Company Profile and Main Business
        9.6.3 Lupin Gynecological Conditions Medications Models, Specifications, and Application
        9.6.4 Lupin Gynecological Conditions Medications Revenue and Gross Margin, 2021-2026
        9.6.5 Lupin Recent Developments
    9.7 Adorshea Bioceutics
        9.7.1 Adorshea Bioceutics Company Information, Head Office, Market Area, and Industry Position
        9.7.2 Adorshea Bioceutics Company Profile and Main Business
        9.7.3 Adorshea Bioceutics Gynecological Conditions Medications Models, Specifications, and Application
        9.7.4 Adorshea Bioceutics Gynecological Conditions Medications Revenue and Gross Margin, 2021-2026
        9.7.5 Adorshea Bioceutics Recent Developments
    9.8 Duchesnay
        9.8.1 Duchesnay Company Information, Head Office, Market Area, and Industry Position
        9.8.2 Duchesnay Company Profile and Main Business
        9.8.3 Duchesnay Gynecological Conditions Medications Models, Specifications, and Application
        9.8.4 Duchesnay Gynecological Conditions Medications Revenue and Gross Margin, 2021-2026
        9.8.5 Duchesnay Recent Developments
    9.9 Perrigo
        9.9.1 Perrigo Company Information, Head Office, Market Area, and Industry Position
        9.9.2 Perrigo Company Profile and Main Business
        9.9.3 Perrigo Gynecological Conditions Medications Models, Specifications, and Application
        9.9.4 Perrigo Gynecological Conditions Medications Revenue and Gross Margin, 2021-2026
        9.9.5 Perrigo Recent Developments
    9.10 Prestige Consumer Healthcare
        9.10.1 Prestige Consumer Healthcare Company Information, Head Office, Market Area, and Industry Position
        9.10.2 Prestige Consumer Healthcare Company Profile and Main Business
        9.10.3 Prestige Consumer Healthcare Gynecological Conditions Medications Models, Specifications, and Application
        9.10.4 Prestige Consumer Healthcare Gynecological Conditions Medications Revenue and Gross Margin, 2021-2026
        9.10.5 Prestige Consumer Healthcare Recent Developments
    9.11 Combe Incorporated
        9.11.1 Combe Incorporated Company Information, Head Office, Market Area, and Industry Position
        9.11.2 Combe Incorporated Company Profile and Main Business
        9.11.3 Combe Incorporated Gynecological Conditions Medications Models, Specifications, and Application
        9.11.4 Combe Incorporated Gynecological Conditions Medications Revenue and Gross Margin, 2021-2026
        9.11.5 Combe Incorporated Recent Developments
    9.12 Femcorp
        9.12.1 Femcorp Company Information, Head Office, Market Area, and Industry Position
        9.12.2 Femcorp Company Profile and Main Business
        9.12.3 Femcorp Gynecological Conditions Medications Models, Specifications, and Application
        9.12.4 Femcorp Gynecological Conditions Medications Revenue and Gross Margin, 2021-2026
        9.12.5 Femcorp Recent Developments
    9.13 Beijing Tongrentang
        9.13.1 Beijing Tongrentang Company Information, Head Office, Market Area, and Industry Position
        9.13.2 Beijing Tongrentang Company Profile and Main Business
        9.13.3 Beijing Tongrentang Gynecological Conditions Medications Models, Specifications, and Application
        9.13.4 Beijing Tongrentang Gynecological Conditions Medications Revenue and Gross Margin, 2021-2026
        9.13.5 Beijing Tongrentang Recent Developments
    9.14 Qianjin Pharmaceutical
        9.14.1 Qianjin Pharmaceutical Company Information, Head Office, Market Area, and Industry Position
        9.14.2 Qianjin Pharmaceutical Company Profile and Main Business
        9.14.3 Qianjin Pharmaceutical Gynecological Conditions Medications Models, Specifications, and Application
        9.14.4 Qianjin Pharmaceutical Gynecological Conditions Medications Revenue and Gross Margin, 2021-2026
        9.14.5 Qianjin Pharmaceutical Recent Developments
    9.15 Enwei Pharmaceutical
        9.15.1 Enwei Pharmaceutical Company Information, Head Office, Market Area, and Industry Position
        9.15.2 Enwei Pharmaceutical Company Profile and Main Business
        9.15.3 Enwei Pharmaceutical Gynecological Conditions Medications Models, Specifications, and Application
        9.15.4 Enwei Pharmaceutical Gynecological Conditions Medications Revenue and Gross Margin, 2021-2026
        9.15.5 Enwei Pharmaceutical Recent Developments
    9.16 Yunnan Baiyao
        9.16.1 Yunnan Baiyao Company Information, Head Office, Market Area, and Industry Position
        9.16.2 Yunnan Baiyao Company Profile and Main Business
        9.16.3 Yunnan Baiyao Gynecological Conditions Medications Models, Specifications, and Application
        9.16.4 Yunnan Baiyao Gynecological Conditions Medications Revenue and Gross Margin, 2021-2026
        9.16.5 Yunnan Baiyao Recent Developments
10 Conclusion
11 Appendix
    11.1 Research Methodology
    11.2 Data Source
        11.2.1 Secondary Sources
        11.2.2 Primary Sources
    11.3 Market Estimation Model
    11.4 Disclaimer
title

Table of Figures

List of Tables
 Table 1. Gynecological Conditions Medications Consumption Value & CAGR: Japan VS Global, 2021-2032, US$ Million
 Table 2. Gynecological Conditions Medications Market Restraints
 Table 3. Gynecological Conditions Medications Market Trends
 Table 4. Gynecological Conditions Medications Industry Policy
 Table 5. Global Gynecological Conditions Medications Revenue by Company, 2021-2026, US$ million, Ranked Based on Revenue in 2025
 Table 6. Global Gynecological Conditions Medications Revenue Share by Company, 2021-2026, Ranked by Data of 2025
 Table 7. Global Gynecological Conditions Medications Manufacturers Market Concentration Ratio (CR3 and HHI)
 Table 8. Global Gynecological Conditions Medications Mergers & Acquisitions, Expansion Plans
 Table 9. Global Gynecological Conditions Medications Major Companies Product Type
 Table 10. Head Office and Area Served of Key Players
 Table 11. Japan Gynecological Conditions Medications Revenue by Company, 2021-2026, US$ million, Ranked Based on Revenue in 2025
 Table 12. Japan Gynecological Conditions Medications Revenue Market Share by Company, 2021-2026
 Table 13. Global Key Players of Gynecological Conditions Medications Upstream (Raw Materials)
 Table 14. Global Gynecological Conditions Medications Typical Customers
 Table 15. Gynecological Conditions Medications Typical Distributors
 Table 16. by Type, Global Gynecological Conditions Medications Consumption Value & CAGR, 2021 VS 2025 VS 2032, US$ Million
 Table 17. by Application, Global Gynecological Conditions Medications Consumption Value & CAGR, 2021 VS 2025 VS 2032, US$ Million
 Table 18. By Region, Global Gynecological Conditions Medications Consumption Value, 2021 VS 2025 VS 2032, US$ Million
 Table 19. By Region, Global Gynecological Conditions Medications Consumption Value, 2021-2032, US$ Million
 Table 20. By Country, Global Gynecological Conditions Medications Consumption Value & CAGR, 2021 VS 2025 VS 2032, US$ Million
 Table 21. By Country, Global Gynecological Conditions Medications Consumption Value, 2021-2032, US$ Million
 Table 22. By Country, Global Gynecological Conditions Medications Consumption Value Market Share, 2021-2032
 Table 23. Bayer Company Information, Head Office, Market Area, and Industry Position
 Table 24. Bayer Company Profile and Main Business
 Table 25. Bayer Gynecological Conditions Medications Models, Specifications, and Application
 Table 26. Bayer Gynecological Conditions Medications Revenue and Gross Margin, US$ Million, 2021-2026
 Table 27. Bayer Recent Developments
 Table 28. Pfizer Company Information, Head Office, Market Area, and Industry Position
 Table 29. Pfizer Company Profile and Main Business
 Table 30. Pfizer Gynecological Conditions Medications Models, Specifications, and Application
 Table 31. Pfizer Gynecological Conditions Medications Revenue and Gross Margin, US$ Million, 2021-2026
 Table 32. Pfizer Recent Developments
 Table 33. Sanofi Company Information, Head Office, Market Area, and Industry Position
 Table 34. Sanofi Company Profile and Main Business
 Table 35. Sanofi Gynecological Conditions Medications Models, Specifications, and Application
 Table 36. Sanofi Gynecological Conditions Medications Revenue and Gross Margin, US$ Million, 2021-2026
 Table 37. Sanofi Recent Developments
 Table 38. Fuji Pharma Company Information, Head Office, Market Area, and Industry Position
 Table 39. Fuji Pharma Company Profile and Main Business
 Table 40. Fuji Pharma Gynecological Conditions Medications Models, Specifications, and Application
 Table 41. Fuji Pharma Gynecological Conditions Medications Revenue and Gross Margin, US$ Million, 2021-2026
 Table 42. Fuji Pharma Recent Developments
 Table 43. Edenbridge Pharmaceuticals Company Information, Head Office, Market Area, and Industry Position
 Table 44. Edenbridge Pharmaceuticals Company Profile and Main Business
 Table 45. Edenbridge Pharmaceuticals Gynecological Conditions Medications Models, Specifications, and Application
 Table 46. Edenbridge Pharmaceuticals Gynecological Conditions Medications Revenue and Gross Margin, US$ Million, 2021-2026
 Table 47. Edenbridge Pharmaceuticals Recent Developments
 Table 48. Lupin Company Information, Head Office, Market Area, and Industry Position
 Table 49. Lupin Company Profile and Main Business
 Table 50. Lupin Gynecological Conditions Medications Models, Specifications, and Application
 Table 51. Lupin Gynecological Conditions Medications Revenue and Gross Margin, US$ Million, 2021-2026
 Table 52. Lupin Recent Developments
 Table 53. Adorshea Bioceutics Company Information, Head Office, Market Area, and Industry Position
 Table 54. Adorshea Bioceutics Company Profile and Main Business
 Table 55. Adorshea Bioceutics Gynecological Conditions Medications Models, Specifications, and Application
 Table 56. Adorshea Bioceutics Gynecological Conditions Medications Revenue and Gross Margin, US$ Million, 2021-2026
 Table 57. Adorshea Bioceutics Recent Developments
 Table 58. Duchesnay Company Information, Head Office, Market Area, and Industry Position
 Table 59. Duchesnay Company Profile and Main Business
 Table 60. Duchesnay Gynecological Conditions Medications Models, Specifications, and Application
 Table 61. Duchesnay Gynecological Conditions Medications Revenue and Gross Margin, US$ Million, 2021-2026
 Table 62. Duchesnay Recent Developments
 Table 63. Perrigo Company Information, Head Office, Market Area, and Industry Position
 Table 64. Perrigo Company Profile and Main Business
 Table 65. Perrigo Gynecological Conditions Medications Models, Specifications, and Application
 Table 66. Perrigo Gynecological Conditions Medications Revenue and Gross Margin, US$ Million, 2021-2026
 Table 67. Perrigo Recent Developments
 Table 68. Prestige Consumer Healthcare Company Information, Head Office, Market Area, and Industry Position
 Table 69. Prestige Consumer Healthcare Company Profile and Main Business
 Table 70. Prestige Consumer Healthcare Gynecological Conditions Medications Models, Specifications, and Application
 Table 71. Prestige Consumer Healthcare Gynecological Conditions Medications Revenue and Gross Margin, US$ Million, 2021-2026
 Table 72. Prestige Consumer Healthcare Recent Developments
 Table 73. Combe Incorporated Company Information, Head Office, Market Area, and Industry Position
 Table 74. Combe Incorporated Company Profile and Main Business
 Table 75. Combe Incorporated Gynecological Conditions Medications Models, Specifications, and Application
 Table 76. Combe Incorporated Gynecological Conditions Medications Revenue and Gross Margin, US$ Million, 2021-2026
 Table 77. Combe Incorporated Recent Developments
 Table 78. Femcorp Company Information, Head Office, Market Area, and Industry Position
 Table 79. Femcorp Company Profile and Main Business
 Table 80. Femcorp Gynecological Conditions Medications Models, Specifications, and Application
 Table 81. Femcorp Gynecological Conditions Medications Revenue and Gross Margin, US$ Million, 2021-2026
 Table 82. Femcorp Recent Developments
 Table 83. Beijing Tongrentang Company Information, Head Office, Market Area, and Industry Position
 Table 84. Beijing Tongrentang Company Profile and Main Business
 Table 85. Beijing Tongrentang Gynecological Conditions Medications Models, Specifications, and Application
 Table 86. Beijing Tongrentang Gynecological Conditions Medications Revenue and Gross Margin, US$ Million, 2021-2026
 Table 87. Beijing Tongrentang Recent Developments
 Table 88. Qianjin Pharmaceutical Company Information, Head Office, Market Area, and Industry Position
 Table 89. Qianjin Pharmaceutical Company Profile and Main Business
 Table 90. Qianjin Pharmaceutical Gynecological Conditions Medications Models, Specifications, and Application
 Table 91. Qianjin Pharmaceutical Gynecological Conditions Medications Revenue and Gross Margin, US$ Million, 2021-2026
 Table 92. Qianjin Pharmaceutical Recent Developments
 Table 93. Enwei Pharmaceutical Company Information, Head Office, Market Area, and Industry Position
 Table 94. Enwei Pharmaceutical Company Profile and Main Business
 Table 95. Enwei Pharmaceutical Gynecological Conditions Medications Models, Specifications, and Application
 Table 96. Enwei Pharmaceutical Gynecological Conditions Medications Revenue and Gross Margin, US$ Million, 2021-2026
 Table 97. Enwei Pharmaceutical Recent Developments
 Table 98. Yunnan Baiyao Company Information, Head Office, Market Area, and Industry Position
 Table 99. Yunnan Baiyao Company Profile and Main Business
 Table 100. Yunnan Baiyao Gynecological Conditions Medications Models, Specifications, and Application
 Table 101. Yunnan Baiyao Gynecological Conditions Medications Revenue and Gross Margin, US$ Million, 2021-2026
 Table 102. Yunnan Baiyao Recent Developments


List of Figures
 Figure 1. Gynecological Conditions Medications Picture
 Figure 2. Global Gynecological Conditions Medications Consumption Value, (US$ million) & (2021-2032)
 Figure 3. Japan Gynecological Conditions Medications Consumption Value, (US$ million) & (2021-2032)
 Figure 4. By Consumption Value, Japan Gynecological Conditions Medications Market Share of Global, 2021-2032
 Figure 5. Global Gynecological Conditions Medications Market Share by Company, (Tier 1, Tier 2, and Tier 3), 2025
 Figure 6. Japan Gynecological Conditions Medications Key Participants, Market Share, 2025
 Figure 7. Gynecological Conditions Medications Industry Chain
 Figure 8. Gynecological Conditions Medications Procurement Model
 Figure 9. Gynecological Conditions Medications Sales Model
 Figure 10. Gynecological Conditions Medications Sales Channels, Direct Sales, and Distribution
 Figure 11. Chinese Patent Medicine
 Figure 12. Chemical Synthesis Medicine
 Figure 13. by Type, Global Gynecological Conditions Medications Consumption Value, 2021-2032, US$ Million
 Figure 14. by Type, Global Gynecological Conditions Medications Consumption Value Market Share, 2021-2032
 Figure 15. Hospital
 Figure 16. Pharmacy
 Figure 17. Online
 Figure 18. by Application, Global Gynecological Conditions Medications Consumption Value, 2021-2032, US$ Million
 Figure 19. by Application, Global Gynecological Conditions Medications Revenue Market Share, 2021-2032
 Figure 20. By Region, Global Gynecological Conditions Medications Consumption Value Market Share, 2021-2032
 Figure 21. North America Gynecological Conditions Medications Consumption Value & Forecasts, 2021-2032, US$ Million
 Figure 22. By Country, North America Gynecological Conditions Medications Consumption Value Market Share, 2025
 Figure 23. Europe Gynecological Conditions Medications Consumption Value & Forecasts, 2021-2032, US$ Million
 Figure 24. By Country, Europe Gynecological Conditions Medications Consumption Value Market Share, 2025
 Figure 25. Asia Pacific Gynecological Conditions Medications Consumption Value & Forecasts, 2021-2032, US$ Million
 Figure 26. By Country/Region, Asia Pacific Gynecological Conditions Medications Consumption Value Market Share, 2025
 Figure 27. South America Gynecological Conditions Medications Consumption Value & Forecasts, 2021-2032, US$ Million
 Figure 28. By Country, South America Gynecological Conditions Medications Consumption Value Market Share, 2025
 Figure 29. Middle East & Africa Gynecological Conditions Medications Consumption Value & Forecasts, 2021-2032, US$ Million
 Figure 30. United States Gynecological Conditions Medications Consumption Value, 2021-2032, US$ Million
 Figure 31. by Type, United States Gynecological Conditions Medications Consumption Value Market Share, 2025 VS 2032
 Figure 32. by Application, United States Gynecological Conditions Medications Consumption Value Market Share, 2025 VS 2032
 Figure 33. Europe Gynecological Conditions Medications Consumption Value, 2021-2032, US$ Million
 Figure 34. by Type, Europe Gynecological Conditions Medications Consumption Value Market Share, 2025 VS 2032
 Figure 35. by Application, Europe Gynecological Conditions Medications Consumption Value Market Share, 2025 VS 2032
 Figure 36. China Gynecological Conditions Medications Consumption Value, 2021-2032, US$ Million
 Figure 37. by Type, China Gynecological Conditions Medications Consumption Value Market Share, 2025 VS 2032
 Figure 38. by Application, China Gynecological Conditions Medications Consumption Value Market Share, 2025 VS 2032
 Figure 39. Japan Gynecological Conditions Medications Consumption Value, 2021-2032, US$ Million
 Figure 40. by Type, Japan Gynecological Conditions Medications Consumption Value Market Share, 2025 VS 2032
 Figure 41. by Application, Japan Gynecological Conditions Medications Consumption Value Market Share, 2025 VS 2032
 Figure 42. South Korea Gynecological Conditions Medications Consumption Value, 2021-2032, US$ Million
 Figure 43. by Type, South Korea Gynecological Conditions Medications Consumption Value Market Share, 2025 VS 2032
 Figure 44. by Application, South Korea Gynecological Conditions Medications Consumption Value Market Share, 2025 VS 2032
 Figure 45. Southeast Asia Gynecological Conditions Medications Consumption Value, 2021-2032, US$ Million
 Figure 46. by Type, Southeast Asia Gynecological Conditions Medications Consumption Value Market Share, 2025 VS 2032
 Figure 47. by Application, Southeast Asia Gynecological Conditions Medications Consumption Value Market Share, 2025 VS 2032
 Figure 48. India Gynecological Conditions Medications Consumption Value, 2021-2032, US$ Million
 Figure 49. by Type, India Gynecological Conditions Medications Consumption Value Market Share, 2025 VS 2032
 Figure 50. by Application, India Gynecological Conditions Medications Consumption Value Market Share, 2025 VS 2032
 Figure 51. Middle East & Africa Gynecological Conditions Medications Consumption Value, 2021-2032, US$ Million
 Figure 52. by Type, Middle East & Africa Gynecological Conditions Medications Consumption Value Market Share, 2025 VS 2032
 Figure 53. by Application, Middle East & Africa Gynecological Conditions Medications Consumption Value Market Share, 2025 VS 2032
 Figure 54. Research Methodology
 Figure 55. Breakdown of Primary Interviews
 Figure 56. Bottom-up Approaches
 Figure 57. Top-down Approaches

お見積>

サンプルお申込み>

今すぐ購入>

PDFダウンロード>

当社から購入のメリット
  • jiantou

    多言語（英語、日本語）のサンプル提供

  • jiantou

    プロフェッショナルな日本語翻訳を提供

  • jiantou

    請求書、クレジットカードでのお支払いが可能です

  • jiantou

    必要なチャプターやカスタマイズされたレポートの注文が可能

  • jiantou

    購入後、アナリストに直接連絡することができます

購入方法
shunxu

  • 必要な言語とバージョンのレポート選択

  • レポート要件と見積もり依頼

  • 電子メールによる注文

  • レポートの入手（英語版は2～4営業日、日本語版は8～10営業日）

  • クレジットカード決済、オフライン振込に対応（後払い可）

※当サイトに掲載されていない海外調査報告書も当社経由でご購入いただけますので、お問い合わせください。

※市場調査レポートの購入や市場調査をご希望の場合は、実績と信頼のある株式会社市場調査センターにお任せください。

*フォーチュン500企業は当社と緊密な協力関係を確立しています

クライアント様（例）
ご利用ガイド
利用規約よくあるご質問プライバシーポリシー支払い方法と購入ガイド
お電話でのお問い合わせ
email050-5840-2692 日本
email0081-50-5840-2692 グローバル
9:00-18:00 (土日・祝日を除く)
底部logo
Copyright 2016-2026 Global Reports著作権所有